121 related articles for article (PubMed ID: 32692734)
41. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
[TBL] [Abstract][Full Text] [Related]
42. Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Russo SM; Ove R; Saif MW
JOP; 2011 Mar; 12(2):92-5. PubMed ID: 21386628
[TBL] [Abstract][Full Text] [Related]
43. Apalutamide OK'd for Some Prostate Cancers.
Cancer Discov; 2018 Apr; 8(4):377. PubMed ID: 29459439
[TBL] [Abstract][Full Text] [Related]
44. ASCO highlights new findings on cancer screening. Discoveries connected to ovarian, cervical, and prostate cancers.
Printz C
Cancer; 2011 Aug; 117(16):3627-9. PubMed ID: 21815131
[No Abstract] [Full Text] [Related]
45. Advancements in the Management of Pancreatic Cancer: 2015 ASCO Gastrointestinal Cancers Symposium (San Francisco, CA, USA. January 15-17, 2015).
Passero FC; Saif MW
JOP; 2015 Mar; 16(2):99-103. PubMed ID: 25791541
[No Abstract] [Full Text] [Related]
46. Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.
Aprile G; Giuliani F; Cordio S; Sartore-Bianchi A; Bencardino K; Ongaro E; Martines C; Giampieri R; Bordonaro R; Siena S; Cascinu S; Scartozzi M
Future Oncol; 2014 May; 10(7):1125-8. PubMed ID: 24947252
[TBL] [Abstract][Full Text] [Related]
47. Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline.
Bekelman JE; Rumble RB; Chen RC; Pisansky TM; Finelli A; Feifer A; Nguyen PL; Loblaw DA; Tagawa ST; Gillessen S; Morgan TM; Liu G; Vapiwala N; Haluschak JJ; Stephenson A; Touijer K; Kungel T; Freedland SJ
J Clin Oncol; 2018 Nov; 36(32):3251-3258. PubMed ID: 30183466
[TBL] [Abstract][Full Text] [Related]
48. Bisphosphonate anticancer activity in prostate cancer and other genitourinary cancers.
Saad F; Mulders P
Anticancer Agents Med Chem; 2012 Feb; 12(2):129-36. PubMed ID: 21864229
[TBL] [Abstract][Full Text] [Related]
49. Updates on radium-223 for castration-resistant prostate cancer presented at the Genitourinary Cancers Symposium, January 7-9, 2016, San Francisco, California.
Barkin J
Can J Urol; 2016 Jun; 23(3):8306-7. PubMed ID: 27347626
[No Abstract] [Full Text] [Related]
50. Physical activity and genitourinary cancer prevention.
Leitzmann MF
Recent Results Cancer Res; 2011; 186():43-71. PubMed ID: 21113760
[TBL] [Abstract][Full Text] [Related]
51. Translational research in pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2011 Mar; 12(2):120-2. PubMed ID: 21386635
[TBL] [Abstract][Full Text] [Related]
52. Novel targets in prostate cancer.
Berthold DR; Moore MJ
Expert Opin Ther Targets; 2006 Oct; 10(5):777-80. PubMed ID: 16981834
[TBL] [Abstract][Full Text] [Related]
53. Suicide in patients with genitourinary malignancies.
de Lima MM; Tobias-Machado M
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28134462
[TBL] [Abstract][Full Text] [Related]
54. ASCO GI: 2014 symposium highlights.
Kachnic LA
Oncology (Williston Park); 2014 Feb; 28(2):150, 152. PubMed ID: 24701704
[No Abstract] [Full Text] [Related]
55. Pancreatic neuroendocrine tumors: role of novel agents. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2011 Mar; 12(2):117-9. PubMed ID: 21386634
[TBL] [Abstract][Full Text] [Related]
56. Maximizing outcomes in genitourinary cancers across the treatment continuum.
Fitzpatrick JM; Bellmunt J; Dreicer R; Fleshner NE; Logothetis CJ; Moul JW; Tombal B; Zlotta A
BJU Int; 2011 Apr; 107 Suppl 2():1-12. PubMed ID: 21382149
[TBL] [Abstract][Full Text] [Related]
57. Other Solid Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner.
J Adv Pract Oncol; 2021 Aug; 12(6):629-632. PubMed ID: 34540332
[No Abstract] [Full Text] [Related]
58. Gynecologic Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner.
J Adv Pract Oncol; 2021 Aug; 12(6):621-628. PubMed ID: 34540331
[No Abstract] [Full Text] [Related]
59. [A hundred cases of multiple primary neoplasms in association with genitourinary cancer].
Kakizaki H; Abe Y; Sugano O; Kato H
Nihon Hinyokika Gakkai Zasshi; 1992 Nov; 83(11):1841-6. PubMed ID: 1479754
[TBL] [Abstract][Full Text] [Related]
60. Intraductal papillary mucinous neoplasia (IPMN). Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Bussom S; Saif MW
JOP; 2010 Mar; 11(2):131-4. PubMed ID: 20208320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
